Monday, January 17, 2011 5:11:55 PM
Smarter is not the problem on these public forums
Its common sense that seems to be so elusive
Recent NFX News
- Nuformix PLC Result of AGM • RNS Regulatory News • 03/19/2024 02:39:02 PM
- Nuformix announces subscription to raise GBP150,000 • Alliance News • 03/01/2024 10:31:01 AM
- Nuformix PLC Subscription to raise £150,000 • RNS Regulatory News • 03/01/2024 07:00:04 AM
- Nuformix PLC Posting of Annual Report and Notice of AGM • UK Regulatory • 01/15/2024 11:30:00 AM
- Nuformix narrows annual loss as develops drug assets • Alliance News • 01/03/2024 10:16:07 AM
- Nuformix PLC Results for the period ended 30 September 2023 • UK Regulatory • 01/03/2024 07:00:00 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 12/18/2023 07:00:00 AM
- Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002 • Alliance News • 10/23/2023 11:38:39 AM
- Nuformix PLC Notice of Allowance of NXP002 Patent in Japan • UK Regulatory • 10/23/2023 06:04:00 AM
- Nuformix to receive milestone payments from Oxilio pact • Alliance News • 09/18/2023 09:20:54 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 09/18/2023 06:00:00 AM
- Nuformix PLC Result of Annual General Meeting • UK Regulatory • 08/24/2023 12:22:00 PM
- Nuformix PLC Notice of AGM • UK Regulatory • 07/31/2023 01:00:00 PM
- Nuformix PLC Holding(s) in Company • UK Regulatory • 07/26/2023 01:55:00 PM
- Nuformix PLC Investor Online Q&A • RNS Non-Regulatory • 06/02/2023 06:00:00 AM
- Nuformix PLC Change of Auditor • UK Regulatory • 05/25/2023 06:00:00 AM
- Nuformix loss narrows; near-term goal to focus on NXP002 asset • Alliance News • 05/22/2023 11:45:14 AM
- Nuformix PLC Unaudited Interim Report • UK Regulatory • 05/22/2023 06:00:00 AM
- Nuformix says NXP002 shows anti-inflammatory effect • Alliance News • 05/18/2023 01:31:17 PM
- Nuformix PLC NXP002 Inflammation and Duration of Action Update • UK Regulatory • 05/18/2023 06:00:00 AM
- Nuformix PLC Holding(s) in Company • UK Regulatory • 04/26/2023 09:55:00 AM
- Nuformix raises GBP70,000 to fund NXP002 programme • Alliance News • 04/17/2023 11:14:54 AM
- Nuformix PLC Subscription to raise GBP70,000 & issue of Warrants • UK Regulatory • 04/17/2023 06:00:00 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM